Anti-factor IX/IXa antibodies
US6391299B1 · kind B1 · utility
19Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 1999 |
| Grant date | May 21, 2002 |
| Priority date | — |
| Expiry date | Jun 25, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies directed against coagulation factors and their use in inhibiting thrombosis are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.